1060 related articles for article (PubMed ID: 19135996)
1. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
[TBL] [Abstract][Full Text] [Related]
2. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis.
Gonzalez-Rey E; Anderson P; González MA; Rico L; Büscher D; Delgado M
Gut; 2009 Jul; 58(7):929-39. PubMed ID: 19136511
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic action of ghrelin in a mouse model of colitis.
Gonzalez-Rey E; Chorny A; Delgado M
Gastroenterology; 2006 May; 130(6):1707-20. PubMed ID: 16697735
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
Gonzalez-Rey E; Chorny A; Varela N; O'Valle F; Delgado M
Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
[TBL] [Abstract][Full Text] [Related]
9. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
10. Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis.
Zhou B; Yuan J; Zhou Y; Ghawji M; Deng YP; Lee AJ; Lee AJ; Nair U; Kang AH; Brand DD; Yoo TJ
Clin Immunol; 2011 Dec; 141(3):328-37. PubMed ID: 21944669
[TBL] [Abstract][Full Text] [Related]
11. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.
Constantin G; Marconi S; Rossi B; Angiari S; Calderan L; Anghileri E; Gini B; Bach SD; Martinello M; Bifari F; Galiè M; Turano E; Budui S; Sbarbati A; Krampera M; Bonetti B
Stem Cells; 2009 Oct; 27(10):2624-35. PubMed ID: 19676124
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
13. N-(3', 4'-dimethoxycinnamonyl) anthranilic acid alleviated experimental colitis by inhibiting autoimmune response and inducing CD4+ CD25+ regulatory T cells production.
Wen Q; Zhou L; Chen H; Zhang Y
J Gastroenterol Hepatol; 2013 Aug; 28(8):1330-8. PubMed ID: 23663055
[TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC
Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175
[TBL] [Abstract][Full Text] [Related]
15. Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis.
Anderson P; Souza-Moreira L; Morell M; Caro M; O'Valle F; Gonzalez-Rey E; Delgado M
Gut; 2013 Aug; 62(8):1131-41. PubMed ID: 22637701
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect.
Gotsman I; Shlomai A; Alper R; Rabbani E; Engelhardt D; Ilan Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):926-32. PubMed ID: 11356912
[TBL] [Abstract][Full Text] [Related]
17. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect.
Shlomai A; Trop S; Gotsman I; Jurim O; Diment J; Alper R; Rabbani E; Engelhardt D; Ilan Y
J Pathol; 2001 Nov; 195(4):498-507. PubMed ID: 11745683
[TBL] [Abstract][Full Text] [Related]
19. Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis.
Kitamura K; Nakamoto Y; Kaneko S; Mukaida N
J Leukoc Biol; 2004 Dec; 76(6):1111-7. PubMed ID: 15339938
[TBL] [Abstract][Full Text] [Related]
20. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
